Half Year Update

Investor meeting at 13:00 BST / 14:00 CEST Paris, France and Camberley, UK – 18 August 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces a half year update in advance of its investor meeting today. http://novacyt.com/wp-content/uploads/2021/08/Novacyt-half-year-update.pdf

Visit Page

Notice of investor meeting

Paris, France and Camberley, UK – 5 August 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), a leading international specialist in clinical diagnostics, announces that it will hold an investor meeting on Wednesday, 18 August 2021, at 13:00 BST / 14:00 CEST. http://novacyt.com/wp-content/uploads/2021/08/Novacyt-Notice-of-Investor-meeting-.pdf

Visit Page

David Allmond announced as CEO following decision by Graham Mullis to retire

Paris, France and Camberley, UK – 29 July 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), a leading international specialist in clinical diagnostics, announces the appointment of David Allmond as CEO and a member of the Board of Directors effective from 18 October 2021. At that time Graham Mullis, having informed the Board that he

Visit Page